Please try another search
For the three months ended 31 March 2022, Ben Tre Pharmaceutical JSC revenues decreased 2% to VND144.83B. Net income totaled VND3.69B vs. loss of VND316.5M. Revenues reflect Gross Sales decrease of 7% to VND145.12B. Net Income reflects Selling Expense - Balancing value decrease of 68% to VND4.86B (expense), Other Non-Operating Income - Balancing v increase from VND140.7M to VND1.2B (income).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 144831.66 | 175756.97 | 134593.81 | 154373.88 |
Gross Profit | 45010.36 | 63457.85 | 39946.23 | 35222.59 |
Operating Income | 3536.29 | 12634.98 | 254.27 | 3168.89 |
Net Income | 3694.73 | 9665.04 | 143.85 | 4132.03 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 797861.8 | 786991.8 | 737218.83 | 760002.55 |
Total Liabilities | 609021.32 | 595784.32 | 555702.77 | 578191.06 |
Total Equity | 188840.48 | 191207.48 | 181516.06 | 181811.49 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -3076.64 | -37582.06 | -32748.63 | -24393.14 |
Cash From Investing Activities | -9053.16 | 77194.27 | 71811.07 | 71931.45 |
Cash From Financing Activities | 2016.56 | -52343.41 | -53844.77 | -48457.52 |
Net Change in Cash | -10061.83 | -12679.8 | -14791.2 | -928.07 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review